AVNS - CIK 0001606498
The table below shows AVANOS MEDICAL, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.60M | $70.50M | $90.30M | $97.00M | $89.00M | $92.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $141.30M | $150.60M | $142.70M | $138.10M | $161.90M | $163.90M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $325.00M |
| $351.40M |
| $356.00M |
| $352.40M |
| $472.60M |
| $474.10M |
| Property, plant & equipment | $111.20M | $115.40M | $114.30M | $109.80M | $109.50M | $110.70M |
| Goodwill | $394.00M | $394.40M | $381.20M | $455.90M | $795.10M | $794.40M |
| Total assets | $1.05B | $1.07B | $1.04B | $1.11B | $1.66B | $1.66B |
| Accounts payable | $52.30M | $54.20M | $48.80M | $46.00M | $54.20M | $51.40M |
| Total current liabilities | $131.20M | $147.90M | $134.60M | $137.20M | $212.90M | $208.20M |
| Long-term debt | $87.30M | $93.40M | $95.70M | $98.00M | $152.60M | $164.90M |
| Total liabilities | $268.00M | $289.70M | $262.70M | $268.40M | $426.50M | $435.80M |
| Retained earnings | -$774.80M | -$778.60M | -$777.20M | -$700.40M | -$309.70M | -$314.00M |
| Total equity | $782.10M | $778.00M | $776.30M | $839.40M | $1.23B | $1.22B |